FDA Calls for Withdrawal of Multiple Myeloma Drug Pepaxto ...Middle East

The drug was granted an accelerated approval, but a confirmatory phase 3 trial raised concerns about safety after showing higher mortality than in the comparator arm. News Alerts

Hence then, the article about fda calls for withdrawal of multiple myeloma drug pepaxto was published today ( Tuesday 20/12/2022 - 06:04 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Calls for Withdrawal of Multiple Myeloma Drug Pepaxto )

Also on site :

• Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
• The deepfake threat is reshaping global politics
• Numbrix 9 - January 27